Management guidance · Q1 FY27 call
Sign up free to see every company in the sector ranking and track Gaudium IVF and Women Health Ltd.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Gaudium IVF and Women Health Ltd
Quarter-by-quarter operating performance
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 14.42 | 26.92 | 31.73 | 24.51 | 30.35 |
| Expenses + | 8.76 | 18.20 | 17.96 | 17.95 | 18.18 |
| Operating Profit | 5.66 | 8.72 | 13.77 | 6.56 | 12.17 |
| OPM % | 39.25% | 32.39% | 43.40% | 26.76% | 40.10% |
| Other Income + | 0.00 | 0.23 | 0.15 | 0.10 | 0.18 |
| Interest | 0.39 | 0.43 | 0.51 | 1.20 | 1.29 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.49 | 0.64 |
| Profit before tax | 4.69 | 8.16 | 12.80 | 4.97 | 10.42 |
| Tax % | 27.72% | 20.96% | 26.64% | 26.96% | 19.77% |
| Net Profit + | 3.40 | 6.46 | 9.38 | 3.63 | 8.36 |
| EPS in Rs | 0.55 | 1.05 | 1.53 | 0.59 | 1.15 |
Financials of Gaudium IVF and Women Health Ltd
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 37 | 44 | 48 | 71 | 104 |
| Expenses + | 23 | 24 | 28 | 42 | 67 |
| Operating Profit | 14 | 20 | 19 | 29 | 38 |
| OPM % | 37% | 46% | 41% | 41% | 36% |
| Other Income + | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 0 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 |
| Tax % | 26% | 26% | 38% | 25% | 24% |
| Net Profit + | 9 | 14 | 10 | 19 | 24 |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Gaudium IVF and Women Health Ltd
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings + | 6 | 12 | 17 | 21 | 25 |
| Other Liabilities + | 3 | 2 | 7 | 22 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed Assets + | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other Assets + | 14 | 18 | 32 | 58 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Financials of Gaudium IVF and Women Health Ltd
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -1 | 24 | 3 | 9 | |
| Cash from Investing Activity + | -1 | -16 | -5 | -15 | |
| Cash from Financing Activity + | 3 | 5 | -1 | 2 | |
| Net Cash Flow | 0 | 13 | -3 | -5 | |
| Free Cash Flow | -2 | 9 | 1 | -0 | |
| CFO/OP | 13% | 141% | 27% | 46% |
Financials of Gaudium IVF and Women Health Ltd
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | 76% | 45% | 49% | 29% |
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnos.'s Q4 FY26 earnings…
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…